REGENEREX PHARMA, INC. Loss Contingency, Receivable
REGENEREX PHARMA, INC. had Loss Contingency, Receivable of $15.77 thousand as of 2025-03-31, per its 10-K filed 2025-06-30.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:LossContingencyReceivable · last filed 2025-06-30
- 2025-03-31: Loss Contingency, Receivable $15.77K.
| Period end | Loss Contingency, Receivable |
|---|---|
| 2025-03-31 | $15.77K 10-K · filed 2025-06-30 |